Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with INCY as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|2.76%||PowerShares Dynamic Biotech &Genome (PBE)||+7.43 (14.75%)|
|1.17%||SPDR Series Trust SPDR S&P Biotech ETF (XBI)||+48.09 (25.52%)|
|0.45%||Schwab U.S. Mid Cap ETF (SCHM)||+3.11 (7.65%)|
Company Description (as filed with the SEC)
Incyte is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. We have a broad pipeline with programs focused primarily in the areas of oncology and inflammation. We focus our efforts on clinical programs that we believe have the greatest likelihood of creating near-and long-term value and on compounds that we believe a company of our size can effectively develop and commercialize on its own, or that we can further develop and commercialize through strategic relationships. Our highest priority programs involve our janus kinase (JAK) inhibitors, which include oral INCB18424 for hematologic and oncology indications and oral INCB28050 for chronic inflammatory and autoimmune diseases. ... More ...
Where does INCY fit in the risk graph?
|Annual EPS Est:||$-0.29|
|Quarterly EPS Est:||-0.11|